Hypoglycemia and Incident Cognitive Dysfunction: A Post Hoc Analysis From the ORIGIN Trial

被引:21
作者
Cukierman-Yaffe, Tali [1 ,2 ,3 ,4 ]
Bosch, Jackie [3 ,4 ,5 ]
Jung, Hyejung [3 ,4 ]
Punthakee, Zubin [3 ,4 ,6 ]
Gerstein, Hertzel C. [3 ,4 ,6 ]
机构
[1] Sheba Med Ctr, Endocrinol Inst, Gertner Inst, Ramat Gan, Israel
[2] Tel Aviv Univ, Sackler Sch Med, Epidemiol Dept, Tel Aviv, Israel
[3] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada
[4] McMaster Univ, Hamilton, ON, Canada
[5] McMaster Univ, Sch Rehabil Sci, Hamilton, ON, Canada
[6] McMaster Univ, Dept Med, Hamilton, ON, Canada
关键词
INSULIN GLARGINE; BASAL INSULIN; OLDER-PEOPLE; TYPE-2; OUTCOMES; DECLINE; RISK;
D O I
10.2337/dc18-0690
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE Epidemiological studies have reported a relationship between severe hypoglycemia, cognitive dysfunction, and dementia in middle-aged and older people with type 2 diabetes. However, whether severe or nonsevere hypoglycemia precedes cognitive dysfunction is unclear. Thus, the aim of this study was to analyze the relationship between hypoglycemia and incident cognitive dysfunction in a group of carefully followed patients using prospectively collected data in the Outcome Reduction with Initial Glargine Intervention (ORIGIN) trial. RESEARCH DESIGN AND METHODS This prospective cohort analysis of data from a randomized controlled trial included individuals with dysglycemia who had additional cardiovascular risk factors and a Mini-Mental State Examination (MMSE) score >= 24 (N = 11,495). Severe and nonsevere hypoglycemic events were collected prospectively during a median follow-up time of 6.2 years. Incident cognitive dysfunction was defined as either reported dementia or an MMSE score of < 24. The hazard of at least one episode of severe or nonsevere hypoglycemia for incident cognitive dysfunction (i. e., the dependent variable) from the time of randomization was estimated using a Cox proportional hazards model after adjusting for baseline cardiovascular disease, diabetes status, treatment allocation, and a propensity score for either form of hypoglycemia. RESULTS This analysis did not demonstrate an association between severe hypoglycemia and incident cognitive impairment either before (hazard ratio [HR] 1.16; 95% CI 0.89, 1.52) or after (HR 1.00; 95% CI 0.76, 1.31) adjusting for the severe hypoglycemia propensities. Conversely, nonsevere hypoglycemia was inversely related to incident cognitive impairment both before (HR 0.59; 95% CI 0.52, 0.68) and after (HR 0.58; 95% CI 0.51, 0.67) adjustment. CONCLUSIONS Hypoglycemia did not increase the risk of incident cognitive dysfunction in 11,495 middle-aged individuals with dysglycemia.
引用
收藏
页码:142 / 147
页数:6
相关论文
共 12 条
  • [1] Severe hypoglycaemia and late-life cognitive ability in older people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study
    Aung, P. P.
    Strachan, M. W. J.
    Frier, B. M.
    Butcher, I.
    Deary, I. J.
    Price, J. F.
    [J]. DIABETIC MEDICINE, 2012, 29 (03) : 328 - 336
  • [2] Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial
    Cukierman-Yaffe, Tali
    Bosch, Jackie
    Diaz, Rafael
    Dyal, Leanne
    Hancu, Nicolae
    Hildebrandt, Pers
    Lanas, Fernando
    Lewis, Basil S.
    Marre, Michel
    Yale, Jean-Francois
    Yusuf, Salim
    Gerstein, Hertzel C.
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (07) : 562 - 572
  • [3] Severe Hypoglycemia and Cognitive Decline in Older People With Type 2 Diabetes: The Edinburgh Type 2 Diabetes Study
    Feinkohl, Insa
    Aung, Phyu Phyu
    Keller, Marketa
    Robertson, Christine M.
    Morling, Joanne R.
    McLachlan, Stela
    Deary, Ian J.
    Frier, Brian M.
    Strachan, Mark W. J.
    Price, Jackie F.
    [J]. DIABETES CARE, 2014, 37 (02) : 507 - 515
  • [4] SCORING NONRESPONSE ON THE MINI-MENTAL STATE EXAMINATION
    FILLENBAUM, GG
    GEORGE, LK
    BLAZER, DG
    [J]. PSYCHOLOGICAL MEDICINE, 1988, 18 (04) : 1021 - 1025
  • [5] Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
    Gerstein, Hertzel C.
    Bosch, Jackie
    Dagenais, Gilles R.
    Diaz, Rafael
    Jung, Hyejung
    Maggioni, Aldo P.
    Pogue, Janice
    Probstfield, Jeffrey
    Ramachandran, Ambady
    Riddle, Matthew C.
    Ryden, Lars E.
    Yusuf, Salim
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (04) : 319 - 328
  • [6] Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy
    Launer, Lenore J.
    Miller, Michael E.
    Williamson, Jeff D.
    Lazar, Ron M.
    Gerstein, Hertzel C.
    Murray, Anne M.
    Sullivan, Mark
    Horowitz, Karen R.
    Ding, Jingzhong
    Marcovina, Santica
    Lovato, Laura C.
    Lovato, James
    Margolis, Karen L.
    O'Connor, Patrick
    Lipkin, Edward W.
    Hirsch, Joy
    Coker, Laura
    Maldjian, Joseph
    Sunshine, Jeffrey L.
    Truwit, Charles
    Davatzikos, Christos
    Bryan, R. Nick
    [J]. LANCET NEUROLOGY, 2011, 10 (11) : 969 - 977
  • [7] Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial
    Mellbin, Linda G.
    Ryden, Lars
    Riddle, Matthew C.
    Probstfield, Jeffrey
    Rosenstock, Julio
    Diaz, Rafael
    Yusuf, Salim
    Gerstein, Hertzel C.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 (40) : 3137 - 3144
  • [8] Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
    Patel, Anushka
    MacMahon, Stephen
    Chalmers, John
    Neal, Bruce
    Billot, Laurent
    Woodward, Mark
    Marre, Michel
    Cooper, Mark
    Glasziou, Paul
    Grobbee, Diederick
    Hamet, Pavel
    Harrap, Stephen
    Heller, Simon
    Liu, Lisheng
    Mancia, Giuseppe
    Mogensen, Carl Erik
    Pan, Changyu
    Poulter, Neil
    Rodgers, Anthony
    Williams, Bryan
    Bompoint, Severine
    de Galan, Bastiaan E.
    Joshi, Rohina
    Travert, Florence
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (24) : 2560 - 2572
  • [9] Predictors of Nonsevere and Severe Hypoglycemia During Glucose-Lowering Treatment With Insulin Glargine or Standard Drugs in the ORIGIN Trial
    Riddle, Matthew C.
    [J]. DIABETES CARE, 2015, 38 (01) : 22 - 28
  • [10] Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society
    Seaquist, Elizabeth R.
    Anderson, John
    Childs, Belinda
    Cryer, Philip
    Dagogo-Jack, Samuel
    Fish, Lisa
    Heller, Simon R.
    Rodriguez, Henry
    Rosenzweig, James
    Vigersky, Robert
    [J]. DIABETES CARE, 2013, 36 (05) : 1384 - 1395